TINNET as the next step in tinnitus research: Towards evidence-based medicine

The Tinnitus Research Initiative (TRI) has come a long way to bring tinnitus research from several scientific fields together. The European funded TINNET, 'Better Understanding the Heterogeneity of Tinnitus to Improve and Develop New Treatments', can be regarded as the next step. It aims at coordination and standardization in tinnitus research and the enlargement of an already existing database with results from clinical trials. This should lead to a statistically relevant basis for tinnitus research. It promises the opportunity of standardized processes to enable tailor-made assessment for individual patients.

“At the start of the TRI in 2006 as a private initiative, there was only little tinnitus research compared to the number of people suffering from it. This research was isolated and results remained within the separated domains of ENT, audiology, psychology, psychiatry, and etcetera”, Dr. Berthold Langguth, head of the tinnitus center of Regensburg University concludes. TRI had the vision to bring disciplines together and to share results and insights. “Back then”, Langguth remembers, “the general assumption and conclusion were: 'Tinnitus cannot be cured, so learn to live with it'. The people involved in TRI, however, shared the belief that tinnitus should be treatable in principle – for instance with brain stimulation– although this treatment nor any other treatment was not proven yet. Their motto was and still is: 'Together for a cure'.” Since then, a lot has been achieved. For many patients, the suffering from tinnitus has been reduced.

Evidence base

“But tinnitus still is a very heterogeneous illness. It is difficult to treat”, says Langguth, “treatment is for a large part still mainly pioneering, the domain of pilot studies.” As yet, there are no clearly evidence based treatment methods except cognitive behavioral therapy (CBT) – which comes in several forms. Langguth: “But this doesn't affect the tinnitus percept itself, CBT has the goal to facilitate coping with it. While this provides important relief in many cases, it is not yet the solution for every patient suffering from tinnitus. Apart from that, there are many, many approaches with different rationales. Hearing loss compensation, optionally combined with forms of auditory stimulation, is widely accepted, but large controlled studies demonstrating the efficacy of these approaches are needed. Various innovative forms of individualized auditory stimulation offer sounds or music in frequency areas in the neighborhood of the tinnitus frequency. These forms of individualized auditory stimulation can interact with the neuronal mechanisms that generate tinnitus and have shown promising results in pilot studies.” But there is still a lot unclear, Langguth emphasizes: “How large are the clinical effects? Which variant works best with which type(s) of patients? What can we expect from pharmacological treatment or magnetic and electric brain stimulation? Before these newly developed treatments can be implemented in clinical routine, a conclusive statistical basis from large studies would be needed.”

New knowledge

The TINNET initiative was initiated to change this. It has now been approved by the European Cooperation in Science and Technology (COST) Committee of Senior Officials, thus ensuring European funding. “With that, we get the opportunity to lift tinnitus research to the next level. We still largely depend on the outcomes of isolated trials with a couple of dozens of heterogeneous patients, which causes results to partly depend on group configuration. When data from similar trials from dozens of centers or more can henceforth be introduced in the database, this opens a lot of opportunities.” Once detailed data from many persons is gathered, it will allow us to derive new knowledge, says Langguth: “We could understand in more detail what forms of tinnitus do exist and what the differences between the various forms are. The goal would be to create a data-based expert system, which would provide guidance of which treatment has the best chances for success in a given patient: So hopefully in some years, we can ask the database what would be the recommendation for a 56 years old male, who suffers from a tonal tinnitus since a noise trauma two years ago, and the database would tell us, that a combination of drug X and auditory stimulation Y is the most promising first-line treatment for this individual.”

Dr. Berthold Langguth held a speech on the TINNET initiative during the 8th TRI international Conference from 10-13 March in Auckland, New Zealand. COST invites tinnitus researchers from as many European countries as possible to participate in the project.

Leendert van der Ent


Photo: Lasse Designen - Fotolia
Hearing researchers can get into gEAR and accelerate discoveries
Hearing researchers can get into gEAR and accelerate discoveries

 

research tools

©gEAR

An online portal has been launched as a hub for accessible, well-organised and curated data to help researchers seeking to advance discoveries to reverse hearing loss. The resource - gEAR - is encouraging worldwide input to its current stash of over 800 datasets.

Hypertension drug losartan may prevent tumour-induced hearing loss, say US researchers
Hypertension drug losartan may prevent tumour-induced hearing loss, say US researchers

 

drug therapy

© Hailshadow/Caymia - iStock

Findings published in the journal Science Translational Medicine suggest a common, low-cost high blood pressure medicine can have a preventive role in tackling acoustic neuroma-related hearing and balance problems.

Biden's corporate scrutiny order prods dormant decision on over-the-counter hearing aids
Biden's corporate scrutiny order prods dormant decision on over-the-counter hearing aids

 

OTC UPDATE

© x-reflexnaja - iStock

US President Joe Biden signed an executive order this July on anticompetitive issues across a range of industries that include hearing. Will his specific call on over-the-counter (OTC) hearing aids finally see sales ringing up?

Get in the mood for EUHA's return to physical...visually
Get in the mood for EUHA's return to physical...visually

 
 

events

© EUHA

A video promoting the 65th International EUHA Congress and Exhibition has been released on YouTube by the organisers of the event, which will take place from September 15 to 17.

Australian acquisition accelerates Amplifon's eastern ambitions
Australian acquisition accelerates Amplifon's eastern ambitions

 
 
 

retail

© Amplifon

Amplifon has announced an agreement to acquire the high-growth Australian hearing care retailer, Bay Audio, which runs a network of over 100 points of sale in high-traffic premiere shopping malls.

Rottweiler hearing loss findings may aid research into hereditary deafness in humans
Rottweiler hearing loss findings may aid research into hereditary deafness in humans

 

genetics

© Vgajic - iStock

Researchers behind a canine deafness study focusing on the cuddly Rottweiler breed are hopeful of opening new routes for investigating human hereditary hearing defects.

EUHA President Beate Gromke talks about September's 65th International Congress of Hearing Aid Acousticians, and the much anticipated return to face-to-face events.
EUHA President Beate Gromke talks about September's 65th International Congress of Hearing Aid Acousticians, and the much anticipated return to face-to-face events.

 
 

EUHA Congress

© EUHA

In any normal year, the EUHA congress would aspire to host close to 9,000 visitors. In 2021, its organisers have responded to calls to return from a digital to an in-person event. In this AWN exclusive interview, EUHA President Beate Gromke explains how expectations are being managed ahead of the September 15-17 event.

Company Directory

New products

Automated customisation reaches new level for Widex with its new portfolio of AI-enabled features: MySoundAutomated customisation reaches new level for Widex with its new portfolio of AI-enabled features: MySound

 
 

Hearing aids

© Widex

Widex USA has announced Widex My Sound, a portfolio of AI features including a new solution that instantly enables intelligent customisation of the company’s MOMENT hearing aids according to users’ activity and listening intent.

 [ ... ]

GN channels new range of Enhance Pro hearing aids through popular audio brand Jabra, launching first through the Costco chainGN channels new range of Enhance Pro hearing aids through popular audio brand Jabra, launching first through the Costco chain

 
 

new product

© GN Hearing

GN Hearing has unveiled Jabra Enhance Pro, a new premium hearing aid line-up selling medical grade hearing aid tech initially through a trusted consumer audio brand link, and in some 700 Costco Hearing Aid Centers around the world.

 [ ... ]

June 15 UK and Ireland availability for Phonak’s long-awaited Roger On remote microphoneJune 15 UK and Ireland availability for Phonak’s long-awaited Roger On remote microphone

 

amplification

© Phonak

Phonak’s new Roger On remote mic, designed to help hearing aid and cochlear implant wearers better understand speech in challenging situations like background noise and over distance, will be available from June 15, 2021 in the UK and Ireland.

 [ ... ]